← Feed

Troendle August J.

SEC Form 4 insider
President & CEO · Medpace Holdings, Inc. ($MEDP)
3 theses · first seen Aug 12, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d22150%-0.7%-0.7%
3d33133%+0.1%+0.2%
1w3300%+3.3%+1.9%
1m33133%+3.0%+1.6%
3m2200%+12.4%+12.4%
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$MEDPSEC Form 4bearish
Troendle August J. · President & CEO at Medpace Holdings, Inc. · 44d ago2 prior · 0% at 3mo
Sold 48,667 @ $623.03 avg · $30,320,929 · 2026-09-29

Form 4: Troendle August J. sold MEDP

Troendle August J. (President & CEO at Medpace Holdings, Inc.) reported an open-market sale of 48,667 shares of MEDP at an average $623.03, roughly $30,320,929, in a Form 4 filed 2026-10-01.

At post $598.08Now $664.24+11.1% since postedas of Nov 9, 11:30 AM ET
1d+0.2%
3d+0.2%
1w+0.8%
1m+9.0%
3m—
6m—
1y—
View filing on SEC.gov →
$MEDPSEC Form 4bearish
Troendle August J. · President & CEO at Medpace Holdings, Inc. · 92d ago2 prior · 0% at 3mo
Sold 11,824 @ $601.49 avg · $7,111,969 · 2026-08-12

Form 4: Troendle August J. sold MEDP

Troendle August J. (President & CEO at Medpace Holdings, Inc.) reported an open-market sale of 11,824 shares of MEDP at an average $601.49, roughly $7,111,969, in a Form 4 filed 2026-08-14.

At post $578.50Now $664.24+14.8% since postedas of Nov 9, 11:30 AM ET
1d—
3d+3.2%
1w+7.3%
1m+1.6%
3m+13.5%
6m—
1y—
View filing on SEC.gov →
$MEDPSEC Form 4bearish
Troendle August J. · President & CEO at Medpace Holdings, Inc. · 94d ago2 prior · 0% at 3mo
Sold 23,144 @ $604.25 avg · $13,984,854 · 2026-08-10

Form 4: Troendle August J. sold MEDP

Troendle August J. (President & CEO at Medpace Holdings, Inc.) reported an open-market sale of 23,144 shares of MEDP at an average $604.25, roughly $13,984,854, in a Form 4 filed 2026-08-12.

At post $596.98Now $664.24+11.3% since postedas of Nov 9, 11:30 AM ET
1d-1.6%
3d-3.1%
1w+1.9%
1m-1.6%
3m+11.3%
6m—
1y—
View filing on SEC.gov →

End of results.